Featured

Welcome

Firstly, I’d like to say welcome. My aim is to deliver some thought-focussed and robust evidence and information for clinicians working in the world of vascular access and infection prevention. This blog is for helping everyday clinicians in accessing current information to improve care to the patient that is evidence-based, but also incorporating through discussion, the knowledge and expertise from like-minded clinicians at improving and advancing the practices of vascular access… while maintaining the patient as the primary focus of our care.

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study

A new publication on Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study from the Journal of Clinical Oncology

Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study

International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections

A recent publication on the International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections from Expert Review of Medical Devices.

 

International experience with minocycline, EDTA and ethanol lock for salvaging of central line associated bloodstream infections

Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters

A recent Open Access publication on Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters from Breast Care: Basic and Clinical Research.

 

Upper-Extremity Deep Vein Thrombosis in Patients With Breast Cancer With Chest Versus Arm Central Venous Port Catheters

The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line–Associated Bloodstream Infections

A recent publication on The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line–Associated Bloodstream Infections from Clinical Infectious Diseases.

The Cost-effectiveness of Antimicrobial Lock Solutions for the Prevention of Central Line–Associated Bloodstream Infections